Report Code: A13372 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Nimodipine Market
Request Now !Nimodipine is marketed under a variety of brand names including Nimotop. It is used to treat a specific type of brain bleeding. It acts as a calcium channel blocker. The body usually responds to bleeding by narrowing the vein to a moderate circulatory system. However, when the bleeding occurs in the brain, the brain suffers more damage. Nimodipine works in the brain as a vasoconstrictor. It constricts the blood flow in brain, during any incident of bleeding in the brain, resulting in less blood loss. It helps in the prevention of brain damage caused by excessive bleeding.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that first emerged in late December in Hubei province of the Wuhan city in China. The virus that causes, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly infectious and is and is transmitted from person to person. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a pandemic on March 11, 2020.
Pharmaceutical and biotech companies along with governments around the globe are working to address the COVID-19 outbreak, from supporting the vaccines development to medicine supply chain planning. Approximately, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a significant increase in the demand for the management of COVID-19. Such increased demand for these drugs has offered huge opportunities for manufacturers of COVID-19 treatment drugs, as many developed countries are experiencing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future owing to the demand for vaccine and the treatment drugs for COVID-19. This in turn is expected to have a significant impact on the nimodipine market.
Top Impacting Factors
Market Trend
New R & D Activities to Form Novel Nimodipine Product
Key Benefits of the Report
Questions Answered in the Nimodipine Market Report
Nimodipine Market Report Highlights
Aspects | Details |
---|---|
By Product Type |
|
By Application |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Omicron Pharma, Arbor Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Heritage Pharma Labs Inc., LUSOCHIMICA S.p.A., Bayer Vital GmbH, ThePharmaNetwork LLC, Bionpharma Inc., Sofgen Pharmaceuticals, Shandong Xinhua |
Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers